Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
about
Atypical hemolytic uremic syndromeClinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in KoreaHemolytic uremic syndromeManagement of hemolytic-uremic syndrome in childrenThree new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancyHUS and TTP in ChildrenHemolytic uremic syndrome: toxins, vessels, and inflammationEculizumab: a review of its use in atypical haemolytic uraemic syndromeA systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage.Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1).aHUS caused by complement dysregulation: new therapies on the horizon.Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.Diagnosis and management of maternal thrombocytopenia in pregnancy.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Thrombotic microangiopathy and associated renal disorders.Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.Atypical HUS: time to take stock of current guidelines and outcome measures?Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series.Postoperative hemolytic uremic syndrome with renal cortical necrosis following laparoscopic hemicolectomy.Diagnosis and management of thrombotic microangiopathy: the role of registries.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.Successful treatment of DEAP-HUS with eculizumab.Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura.How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndromeEculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension.End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.How we manage thrombotic microangiopathies in pregnancy.Whole-exome sequencing of a patient with severe and complex hemostatic abnormalities reveals a possible contributing frameshift mutation in C3AR1.First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients.A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic SyndromeSubclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab.Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic SyndromeTreatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.
P2860
Q21202864-F78ABA37-AFA4-4677-923F-27D0538E7EFBQ26739894-7F892ED3-73DA-40BC-A635-00555DA31A58Q26799054-E7D89724-FAA6-4B93-A726-CD44D0D8EE32Q27002576-13D30CFD-FE72-450A-AD7E-3AE17DE4AADCQ27013643-1B34A3C9-4476-4B51-85F3-D8C0D2FB7662Q27026538-1CB20552-B27B-4FC1-87B4-E1C9E3BFF7E3Q28083347-9146C5DC-9F44-4B6B-95FB-7A5418022C9AQ28302228-FA8AC8AE-98CE-49A0-B253-70D7D9DBF90CQ28661698-D16D485A-B76E-4094-AD5B-58FF5F183F7BQ30405809-D3DFAA38-99ED-45A3-BE70-8A2003F66C55Q33390080-E9016123-16A6-4819-A531-C5EC5BC7E774Q33390198-78EFECE0-CF4C-4054-AF70-F62F0075A8BBQ33392316-B643F350-ADC8-4979-990B-33251366FEBAQ33399130-04AA26A2-1A0B-4659-87E3-760D0E41C0BAQ33401045-1391381D-D85F-4A6F-A727-CAD37B56B50EQ33401403-81AE0C04-80E2-4945-8970-E10721FE3FBAQ33402372-274422AD-E339-4F79-8056-D309CDB6B027Q33403196-AE33AC50-0CB2-498C-A7A7-D9FB6689447FQ33403607-25D0594A-27D1-41EA-BED9-D95CF0E022F0Q33405728-FF312A26-CF38-45C2-ADAE-6E40633425EBQ33406025-C5B1F6DA-2096-4CFB-9914-5DCAFE7D8B7FQ33406251-7703FB5C-3EB6-438B-87FA-857072A6F4A8Q33406887-890B4FD5-A0CE-47F3-88D1-069AD81F4EACQ33408670-A6BC2A29-1F48-48D2-B8A7-044DB38FA4ABQ33408733-3FFCC247-198C-4607-9AE9-53578EB0AF44Q33409198-E26CE97C-6651-4E0D-913F-8077D381C9D9Q33411577-F447DFA8-DDB2-45E6-88DF-E16FF837820EQ33412347-938AE1F6-E09C-4E72-98F4-C5DD751FC778Q33412445-0C9B7097-64AF-4892-8228-B441EAC1DA10Q33418217-B8D163BF-D443-4A04-A291-E6A373874EA0Q33420509-32908F0C-A404-4550-8878-E6F8820C175FQ33422024-AF74BF2C-0573-4FCC-ADCF-B1DDC73E72E7Q33424946-01AFD5F2-41A6-441B-AFCA-ED6BD3094024Q33431084-CCC183AD-1776-482C-B39D-329FE6A6665AQ33434795-8A17BB63-7121-4BBD-82EE-94B8B7A38942Q33435451-27C0DADF-C4C9-4D1E-9748-F0A94E93F91DQ33437634-EDB0D361-E94B-4CB5-9FC8-2B9A2AC1AF7BQ33439105-1F5A55B0-5521-4B2B-9591-38EC48A45093Q33441517-58AE32FE-0FC2-4EE1-877B-FA758A79EBDCQ34005720-6CA6F355-3942-4E01-BF08-0C057A304358
P2860
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@ast
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@en
type
label
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@ast
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@en
prefLabel
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@ast
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@en
P2093
P1476
Clinical practice guidelines f ...... yndrome in the United Kingdom.
@en
P2093
C Mark Taylor
Sam Machin
Tim H J Goodship
working party from the Renal A ...... ritish Transplantation Society
P356
10.1111/J.1365-2141.2009.07916.X
P407
P577
2009-10-11T00:00:00Z